Suppr超能文献

与药物干预相关的安慰剂和反安慰剂效应及机制:伞式综述。

Placebo and nocebo effects and mechanisms associated with pharmacological interventions: an umbrella review.

机构信息

Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy

Muscle and Nerve Center, Houston, Texas, USA.

出版信息

BMJ Open. 2023 Oct 17;13(10):e077243. doi: 10.1136/bmjopen-2023-077243.

Abstract

OBJECTIVES

This review aimed to summarise the existing knowledge about placebo and nocebo effects associated with pharmacological interventions and their mechanisms.

DESIGN

Umbrella review, adopting the Assessment of Multiple Systematic Reviews 2 tool for critical appraisal.

DATA SOURCES

MEDLINE/PubMed, Scopus, Web of Science, PsycINFO, Cochrane Central Register of Controlled Trial were searched in September 2022, without any time restriction, for systematic reviews, narrative reviews, original articles. Results were summarised through narrative synthesis, tables, 95% CI.

OUTCOME MEASURES

Mechanisms underlying placebo/nocebo effects and/or their effect sizes.

RESULTS

The databases search identified 372 studies, for a total of 158 312 participants, comprising 41 systematic reviews, 312 narrative reviews and 19 original articles. Seventy-three per cent of the examined systematic reviews were of high quality.Our findings revealed that mechanisms underlying placebo and/or nocebo effects have been characterised, at least in part, for: pain, non-noxious somatic sensation, Parkinson's disease, migraine, sleep disorders, intellectual disability, depression, anxiety, dementia, addiction, gynaecological disorders, attention-deficit hyperactivity disorder, immune and endocrine systems, cardiovascular and respiratory systems, gastrointestinal disorders, skin diseases, influenza and related vaccines, oncology, obesity, physical and cognitive performance. Their magnitude ranged from 0.08 to 2.01 (95% CI 0.37 to 0.89) for placebo effects and from 0.32 to 0.90 (95% CI 0.24 to 1.00) for nocebo effects.

CONCLUSIONS

This study provides a valuable tool for clinicians and researchers, identifying both results ready for clinical practice and gaps to address in the near future.

FUNDING

Università Cattolica del Sacro Cuore, Milan, Italy with the 'Finanziamento Ponte 2022' grant.

PROSPERO REGISTRATION NUMBER

CRD42023392281.

摘要

目的

本综述旨在总结与药物干预相关的安慰剂和反安慰剂效应及其机制的现有知识。

设计

采用评估多项系统评价 2 工具进行批判性评价的伞状评价。

数据来源

2022 年 9 月,在无时间限制的情况下,检索了 MEDLINE/PubMed、Scopus、Web of Science、PsycINFO 和 Cochrane 对照试验中心注册数据库,以获取系统评价、叙述性评论、原始文章。结果通过叙述性综合、表格和 95%置信区间进行总结。

结局测量

安慰剂/反安慰剂效应的潜在机制及其效应大小。

结果

数据库检索共识别出 372 项研究,共计 158312 名参与者,包括 41 项系统评价、312 项叙述性综述和 19 项原始文章。73%的被检查系统评价为高质量。我们的研究结果表明,至少部分已经描述了安慰剂和/或反安慰剂效应的潜在机制,包括:疼痛、非疼痛躯体感觉、帕金森病、偏头痛、睡眠障碍、智力障碍、抑郁、焦虑、痴呆、成瘾、妇科疾病、注意力缺陷多动障碍、免疫和内分泌系统、心血管和呼吸系统、胃肠道疾病、皮肤病、流感及相关疫苗、肿瘤学、肥胖、身体和认知表现。它们的幅度从安慰剂效应的 0.08 到 2.01(95%置信区间为 0.37 到 0.89)到反安慰剂效应的 0.32 到 0.90(95%置信区间为 0.24 到 1.00)。

结论

本研究为临床医生和研究人员提供了一个有价值的工具,确定了既可以立即应用于临床实践的结果,也确定了未来需要解决的空白。

资金

意大利米兰圣心天主教大学,通过“2022 年桥梁资助”项目资助。

PROSPERO 注册号:CRD42023392281。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/110a/10582987/895415986247/bmjopen-2023-077243f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验